Oral GLP-1 drug promotes substantial weight loss in trial By Jim Schnabel Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions
Consult a qualified healthcare professional before use if you are pregnant, nursing, have any medical conditions, or are taking prescription or over-the-counter medications
Yes, BPC157 can support post-surgery healing, including joint and tendon repair
A peptide half-life chart is a reference tool used by laboratory researchers to quickly compare how long different peptides remain biologically active in plasma or buffer systems
Melanoacanthoma arises primarily on the buccal mucosa and lips but can also occur under the dentures of African-American women